Senior insider sale
EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$3.51M
219.61K shares
What this filing means
DANIELL RICHARD plans to sell 219.61K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $3.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2025ACC: 0001973379-25-000093
Officer· EVP, Europe Commercial
Since Mar 2026
219.61K
Shares to sell
$3.51M
Approx. market value
70.96K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
SHARES FROM ROLLOVER
COMPENSATION
3/5/2025
48.38KRESTRICTED SHARE UNIT AWARD VESTING
COMPENSATION
3/5/2021
22.58KTotal acquired70.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2025 | SHARES FROM ROLLOVER COMPENSATION | 48.38K | — |
3/5/2021 | RESTRICTED SHARE UNIT AWARD VESTING COMPENSATION | 22.58K | — |
| Total | 70.96K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
86.40K
Market value
$1.38M
3/4/2025
—Completed
Units to sell
62.25K
Market value
$999.4K
3/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
70.96K
Market value
$1.12M
3/5/2025
Total
Units
219.61K
Value
$3.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2025 | 86.40K | $1.38M | — | Completed |
3/3/2025 | 62.25K | $999.4K | — | Completed |
| Planned — Approximate Date | ||||
3/5/2025 | 70.96K | $1.12M | NASDAQ | Planned |
| Total | 219.61K | $3.51M | ||